OBJECTIVES: Irritable bowel syndrome (IBS) and chronic idiopathic constipation (CIC) are
functional bowel disorders. Evidence suggests that disturbance in the gastrointestinal …

Abstract Background & Objectives: Constipation-predominant irritable bowel syndrome (IBS–
C) is functional bowel disorders that may involve disturbance of the gastrointestinal …

Background Irritable bowel syndrome (IBS) is a chronic functional bowel disorder.
Disturbances in the gastrointestinal microbiome may be involved in its aetiology. Aim To …

Probiotics and prebiotics in the management of irritable bow... : Current Opinion in Clinical
Nutrition & Metabolic Care Probiotics and prebiotics in the management of irritable bowel …

Irritable bowel syndrome (IBS) is a chronic condition affecting 3%-25% of the general
population. As no curative treatment is available, therapy is aimed at reducing symptoms …

Treatments that target alterations in gut microbiota may be beneficial for patients with
irritable bowel syndrome (IBS). A systematic review and meta-analysis was conducted of …

Background & objectives Irritable bowel syndrome (IBS) is a functional bowel disorder that
may involve disturbance of the gastrointestinal microbiota. We performed a systematic …

Background Irritable bowel syndrome is a functional gastrointestinal disease. Evidence has
suggested that probiotics may benefit IBS symptoms. However, clinical trials remain …

OBJECTIVES: Irritable bowel syndrome (IBS) is a common disorder and available therapies
have limited efficacy. Mucosal inflammation and alterations in gut microflora may contribute …

METHODS: PubMed, Cochrane library, Scopus, Google Scholar, and Clinicaltrial. gov
databases were searched for literature published between September 2007 and December …